M. Abbasifard

Immune dysregulation in osteoarthritis: Mechanisms, biomarkers, and therapeutic opportunities

Osteoarthritis (OA) is increasingly recognized as a heterogeneous, immune-modulated joint disease in which chronic low-grade synovial inflammation contributes to structural degeneration and pain, challenging its historical classification as a purely mechanical disorder. Central to this paradigm shift is the recognition...